Job Summary
This hybrid role focuses on ensuring high quality pharmacovigilance case activities for global Pharma Research and Development programs while working day shifts with no travel requirement. The talent will apply domain expertise in case assessment and regulatory reporting to protect patient safety strengthen product risk management and support evidence based decisions that advance the organizations scientific and societal impact in healthcare.
Responsibilities
- Lead end to end pharmacovigilance case review activities for clinical and post marketing data to ensure accurate and timely evaluation of safety information that supports robust patient protection across all assigned products.
- Manage daily workflows for adverse event case triage and prioritization to maintain regulatory compliant turnaround times while optimizing resource utilization within the hybrid work model.
- Coordinate closely with clinical and research teams to interpret safety signals emerging from Pharma Research and Development studies and to translate these insights into clear documentation for case records and risk assessments.
- Execute detailed case narrative preparation by synthesizing medical data and source documents into coherent and clinically meaningful summaries that support downstream medical review and decision making.
- Perform rigorous quality checks on PV case processing outputs to identify discrepancies trends and systemic issues and drive corrective actions that strengthen overall case integrity.
- Monitor day shift case queues and reporting milestones to ensure adherence to global submission timelines thereby supporting uninterrupted compliance with regional regulatory expectations.
- Engage with safety data management teams to refine coding conventions and data entry standards so that individual case safety reports are consistently structured for reliable analysis and signal detection.
- Collaborate with cross functional stakeholders in safety operations and regulatory units to clarify case requirements and align workflows that contribute to efficient aggregate reporting and risk management planning.
- Apply specialized knowledge of Pharma Research and Development processes to contextualize adverse events within study protocols and investigational product profiles ensuring balanced case evaluation.
- Drive continuous improvement initiatives in PV case processing by proposing practical enhancements to templates checklists and procedural controls that reduce rework and operational risk.
- Support internal audits and inspection readiness activities by maintaining transparent traceability of case handling decisions which reinforces organizational credibility in pharmacovigilance practice.
- Utilize hybrid work tools and collaboration platforms to maintain real time communication with team members and partners ensuring that safety information is shared promptly despite flexible working arrangements.
- Contribute to patient and public health impact by transforming raw safety data into reliable case information that informs label updates risk minimization measures and long term therapeutic confidence.
Qualifications
- Display strong applied experience in Pharma Research and Development workflows including study documentation interpretation and integration of clinical evidence into safety case assessments.
- Show proven capability in pharmacovigilance case processing through hands on involvement in intake validation medical coding narrative creation and tracking of case lifecycle stages.
- Demonstrate familiarity with individual case safety report preparation and submission processes including awareness of regional regulatory expectations and reporting timelines even if exposure has been limited.
- Exhibit solid understanding of adverse event terminology medical concepts and basic pharmacology enabling accurate evaluation and description of clinical scenarios encountered in safety reports.
- Apply structured analytical thinking to identify trends patterns and potential safety signals across multiple cases while maintaining focus on data completeness and consistency.
- Maintain high proficiency with electronic safety databases documentation systems and productivity tools that support hybrid working and secure handling of confidential health information.
- Communicate clearly in written and spoken form with medical and non medical stakeholders to ensure that case summaries and queries are understandable actionable and aligned with compliance needs.
- Embrace quality and compliance culture by adhering to standard operating procedures guidelines and ethical standards that govern pharmacovigilance work in a multinational environment.
- Adapt readily to hybrid work expectations by managing time independently participating in virtual collaboration and sustaining productivity during both onsite and remote activities.
Certifications Required
Preferred certifications include pharmacovigilance or drug safety credentials such as DIA Pharmacovigilance Certificate or similar recognized industry programs.
コグニザントについて
コグニザント(NASDAQ: CTSH)は、AI Builderおよびテクノロジーサービスプロバイダーとして、お客様にフルスタックのAIソリューションを構築することで、AI投資と企業価値を結ぶ架け橋となっています。業界、ビジネスプロセス、エンジニアリングに関する当社の深い専門知識を活かし、組織固有のビジネス環境をテクノロジー・システムに組み込みます。これにより、人間の可能性を最大限に引き出し、確かな成果を実現するとともに、急速に変化する世界においてグローバル企業が常に一歩先を行くための支援を行っています。 詳細については、cognizant.ai をご覧ください。
雇用に関する追加情報
本募集に記載されている報酬情報は、掲載日時点で正確なものです。Cognizantは、適用される法令に従い、いつでも本情報を変更する権利を留保します。
応募者は、対面またはビデオ会議による面接への参加を求められる場合があります。また、各面接の際に、現在有効な州政府または政府発行の身分証明書の提示を求められる場合があります。
Cognizantは機会均等雇用主です。応募および選考において、人種、肌の色、性別、宗教、信条、性的指向、性自認、国籍、障がい、遺伝情報、妊娠、退役軍人の地位、その他連邦法・州法・地方自治体の法律により保護されるいかなる特性に基づく差別も行いません。







